












































mimicking	 osteoarthritis	 in	 presentation.	 Ochronosis	 causes	 damage	 to	 the	 extracellular	
matrix	and	chondrocyte	death.	It	is	hypothesised	that	superoxide	dismutase	(SOD)	may	have	
a	beneficial	effect	on	chondrocytes	and	limit	this	polymerisation	process.	This	research	aims	




cultured	 in	DMEM	containing	HGA,	 SOD	or	 a	 combination	of	both	 for	up	 to	14	days.	 Cell	
viability	was	assessed	using	trypan	blue	assay.	Pigmentation	was	quantified	using	Schmorl’s	





viability	 of	 osteoarticular	 cells.	 All	 C20	 cultures	 suggest	 a	 decrease	 in	 pigmentation	 upon	








This	 suggests	 that	 SOD	 has	 the	 potential	 to	 be	 used	 as	 a	 therapeutic	 approach	 in	 the	
prevention	 of	 ochronosis	 in	 articular	 cartilage.	 Raman	 spectroscopy	 is	 able	 to	 highlight	


































































































































































































Chapter	3	 	  
3.1	 Percentage	Viability	of	C20	Cells	Using	a	Range	of	Concentrations	of	SOD	 54	
3.2	 Percentage	Viability	of	MG63	Cells	Using	a	Range	of	Concentrations	of	SOD	 55	











































6.5	 Loadings	 Plot	 of	 LD1	 Following	 PCA-LDA	 analysis	 of	 all	 C20	 and	 MG63	
Cultures	
89	




























































seen	 a	 rise	 in	 the	 number	 of	 diagnosed	 cases	 of	 AKU.	 This	 suggests	 that	 there	 are	 still	
numerous	unidentified	cases	and	the	current	prevalence	of	the	condition	is	underestimated	
(3,	5).	The	recent	rise	in	the	number	of	cases	of	AKU	in	Jordan	for	example,	can	be	attributed	
to	 increased	 awareness	 of	 the	 condition	 among	 health	 care	 providers	 and	 high	 rates	 of	
consanguineous	 marriages,	 suggesting	 a	 founder	 effect	 (3,	 5).	 This	 raised	 profile	 of	 the	
condition	 has	 enabled	 the	 identification	 of	 more	 HGD	 gene	 variants,	 with	 at	 least	 129	














therefore	 termed	 the	 causative	 substance	 “Alkapton”;	 a	 combination	 of	 the	 Arabic	 word	
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Wolkow	 and	 Bauman	were	 the	 first	 to	 isolate	 and	 identify	 the	 structural	 formula	 of	 the	



















degradation	 pathway	 (Fig.	 1.2)	 (2).	 It	 is	 responsible	 for	 the	 breakdown	 of	 HGA	 to	















in	 the	 formation	 of	 benzoquinone	 acetic	 acid	 (BQA),	 an	 intermediary	 which	 undergoes	
polymerisation	into	ochronotic	pigment.	Whilst	it	is	possible	for	this	reaction	to	occur	by	itself,	
	 20	
it	 is	 enhanced	 in	 an	 alkaline	environment	 (15,	 16).	Although	dark	urine	 is	 a	 characteristic	
symptom	of	 the	disease,	 it	has	been	shown	 that	other	 tyrosine	metabolites	 in	excess	 can	
darken	 urine	 (17,	 18).	 It	 is	 therefore	 usually	 confirmed	 using	 a	 technique	 known	 as	 high	






air,	 except	 Zannoni	et	 al	 have	 shown	 that	 the	whole	 reaction	 is	 catalysed	by	 an	 enzyme,	
termed	homogentisic	acid	polyphenol	oxidase	(21).	This	implies	that	even	those	without	the	
genetic	defect	carry	this	enzyme,	which	would	not	incur	any	evolutionary	advantage.	Taylor	
et	 al	 therefore	 postulated	 that	 Tyrosinase,	 an	 enzyme	 involved	 in	 melanin	 synthesis,	 is	
responsible	for	producing	the	melanin	like	ochronotic	pigment.	This	is	because	the	melanin	











Ochronosis	 is	 found	 in	 a	 variety	 of	 collagenous	 tissues.	 HGA	 polymerises	 into	 ochronotic	
pigment,	which	preferentially	binds	to	cartilage	in	joints	and	aortic	valves	(26).	Discolouration	
can	also	be	noticed	clearly	 in	the	sclera	of	eyes	and	pinna	of	ears	and	can	affect	the	renal	











spine.	X-rays	 show	 features	 similar	 to	osteoarthritis	 (OA),	 including	 joint	 space	narrowing,	
subchondral	 sclerosis	 and	 subchondral	 cysts.	 Clinically,	 the	 patient	 presents	 with	 sharp	
debilitating	back	pain	which	progresses	with	time	to	peripheral	weight	bearing	joints	such	as	
the	 hips	 and	 knees	 (7,	 30).	 Symptoms	 then	 continue	 to	 develop;	 thoracic	 kyphosis	 and	
reduced	 chest	 expansion	 due	 to	 osteoarthropathy	 of	 the	 spine	 are	 seen	 after	 the	 fourth	





There	 are	 still	 gaps	 however	 in	 the	 understanding	 of	 the	 pathogenesis	 of	 ochronosis	 and	
ochronotic	 osteoarthropathy.	 The	 initiating	 factor/factors	 of	 ochronosis	 are	 currently	
unknown.	 It	 has	 been	 observed	 that	 there	 is	 an	 initial	 period	where	 connective	 tissue	 is	
resistant	to	ochronosis.	This	is	known	because	ochronosis	isn’t	seen	until	early	adulthood	(1,	
31).	This	therefore	suggests	there	are	protective	mechanisms	in	connective	tissue	preventing	
ochronosis,	 which	 are	 currently	 unknown.	 It	 is	 hypothesised	 that	 the	 tissue	 undergoes	
stresses	 which	 remove	 protective	 factors	 such	 as	 proteoglycans,	 enabling	 ochronotic	
polymers	to	bind	to	collagen	fibres	in	specific	areas,	as	shown	by	Taylor	et	al	(1,	32).	Whilst	
the	 stressors	are	currently	unknown,	 inferences	can	be	made.	 IL-6	 is	a	 catabolic	 cytokine,	
released	during	an	inflammatory	response.	Research	has	shown	that	IL-6	plays	a	role	in	the	
pigmentation	 process.	 IL-6	 has	 been	 shown	 to	 dysregulate	 antioxidant	 defences	 in	






the	 biochemical	 and	 biomechanical	 properties	 of	 collagen,	 causing	 further	 damage	 and	










HGA	 produced.	 Unfortunately,	 trials	 have	 shown	 this	 method	 as	 being	 ineffective	 and	
impractical.	 If	 this	 treatment	 is	 implemented,	 intensive	 specialist	 supervision	 is	 required	
during	the	growth	period.	As	well	as	this,	endogenous	catabolism	of	protein	results	in	tyrosine	
















Recent	 research	however	 is	 looking	at	 alternative	antioxidants	which	are	not	 cofactors	 to	
	 24	






a	 preventative	 treatment,	 by	 aims	 of	 preventing	 ochronosis.	 It	 is	 already	 an	 established	
treatment,	 approved	 by	 the	 Food	 and	 Drug	 Administration	 (FDA),	 in	 the	management	 of	
hereditary	tyrosinemia	type	I.	The	first	round	of	trials	for	AKU	have	shown	promising	results	
with	 urinary	 HGA	 levels	 decreasing	 in	 a	 dose	 dependant	manner.	 	 Although	 it	 is	 an	 FDA	
approved	treatment,	there	are	still	safety	concerns	with	Nitisinone.	Some	of	the	side	effects	
have	the	potential	to	cause	ocular	and	neurological	complications,	such	as	corneal	irritation,	






As	 there	 is	no	 licensed	 therapy	 for	AKU,	management	 is	achieved	via	physiotherapy,	 joint	
replacement	and	pain	relief	(2).	Physiotherapy	aims	to	improve	range	of	movements	in	joints,	
whilst	 pain	 management	 is	 achieved	 via	 medications	 and	 physical	 interventions	 such	 as	













is	 approximately	 60	 percent	 of	 the	 bone	 matrix	 and	 is	 constituted	 mainly	 of	 calcium	
hydroxyapatite	 crystals.	 These	 crystals	 surround	 the	 collagen	 fibres	 (organic	 matrix)	 in	 a	
process	 known	as	mineralisation.	 The	 type	 I	 collagen	 fibres	 form	about	90	percent	of	 the	












Histologically,	 bone	 tissue	 is	 known	 to	 have	 two	 variations;	 cortical	 (compact)	 bone,	 and	
trabecular	 (cancellous)	 bone.	 In	 cortical	 bone	 the	 buildings	 blocks	 are	 known	 as	 osteons.	
Around	a	central	canal	are	layers	of	concentric	lamellae.	Within	these	lamellae	are	osteocytes	
which	have	become	embedded.	The	osteocytes	communicate	with	each	other	through	small	















movement	 between	 joints	 and	 evenly	 distributes	 the	 load	 to	 the	 underlying	 subchondral	







present,	 and	 they	 aid	 in	 forming	 and	maintaining	 the	 structure	 of	 type	 II	 collagen.	 Three	






chondroitin	 sulphate	 (CS)	 and	 keratan	 sulphate	 glycosaminoglycan	 (GAG)	 molecules,	 are	
attached	 to	 a	 core	 protein	 via	 sugar	 bonds	 to	 form	 the	 proteoglycan	 molecule.	 These	






acts	 as	 a	 binding	 site	 for	 several	 aggrecan	 molecules	 resulting	 in	 a	 large	 proteoglycan	
aggregate	(45).		
	
Histologically	articular	 cartilage	consists	of	 four	 zones	 (I-IV)	 (Fig.	1.3).	 The	 superficial	 zone	
(zone	I)	is	responsible	for	protecting	the	lower	layers	from	sheer	stress,	and	acts	as	a	barrier	











calcified	and	uncalcified	cartilage,	known	as	the	tidemark.	Zone	 IV	 is	responsible	 for	 fixing	














the	 properties	 of	 cartilage.	 Previous	 experiments	 have	 shown	 that	 pigment	 deposition	 is	
observed	 intra-	 and	 extracellularly,	 which	 replicates	 the	 pathological	 picture	 of	 articular	
cartilage	in	vivo	(2,	25).	MG63	cells	are	osteosarcoma	cell	lines.	They	have	been	used	as	an	in	
vitro	model	to	investigate	ochronosis.	Unlike	in	vivo,	these	cells	have	shown	that	they	pigment	





OA	 is	 the	most	 common	 form	of	 arthritis,	 commonly	associated	with	ageing	 (49).	OA	 is	 a	













• Crepitus		 • Joint	pain	
• Joint	effusion	+/-	inflammation	 • Short	lasting	morning	stiffness		
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It	 is	currently	not	known	where	 in	the	body	ochronosis	 is	 initiated.	Studies	however,	have	
shown	that	fresh	serum	and	urine	samples	from	AKU	patients	only	contain	HGA	molecules.	














mechanical	 stress	 (25,	 33,	 34).	 This	 enables	 ROS	 produced	 by	 polymerisation	 of	 HGA	 to	
damage	 proteoglycans.	 Loss	 of	 proteoglycans	 from	 the	 ECM	 is	 thought	 to	 enable	



















Fig.	 1.6.	 Schematic	 representation	 of	 the	 proposed	 role	 superoxide	 anions	 have	 in	 the	 initiation	 of	
ochronosis,	and	their	role	in	enabling	the	binding	of	ochronotic	pigment	to	collagen	fibrils.	In	normal	aging	
superoxide	anions	are	involved	in	cartilage	degradation,	suggesting	its	role	in	the	pathogenesis	of	OA.	In	






























The	wavelengths	of	 the	Raman	scatter	are	plotted	as	a	spectrum	of	 intensity	 (a.u)	against	









begins	 to	 occur	within	 the	 body,	 from	 the	 third	 decade	 onwards.	 Ochronosis	 occurs	 in	 a	
variety	of	collagenous	tissues.	HGA	polymerises	into	ochronotic	pigment,	and	preferentially	














peroxide	 and	 oxygen	 (61).	 Studies	 have	 shown	 that	 ROS	 are	 involved	 in	 the	 OA	 disease	
process	due	to	a	decrease	in	SOD	(63).	Due	to	OA	and	AKU	sharing	similar	pathophysiological	
mechanisms,	 it	 can	 be	 hypothesised	 that	 a	 potential	 deficit/inactivity	 of	 SOD	 in	 articular	
cartilage	of	patients	with	AKU,	may	be	a	contributing	factor	to	its	pathogenesis	(1,	25).	
	
Structural	 analysis	 has	 enabled	 significant	 advancement	 in	 AKU	 research,	 such	 as	 the	
discovery	of	novel	cartilage	and	bone	phenotypes	(80).	It	is	therefore	likely	that	using	a	novel	
analytical	 technique	 will	 provide	 new	 insights	 into	 the	 pathogenesis	 of	 AKU.	 Raman	
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C20,	 were	 purchased	 pre-mixed	 with	 5ml	 (1%)	 L-Glutamine	 (Sigma	 Aldrich,	 UK).	 Both	
mediums	 were	 then	 supplemented	 with	 50ml	 (10%)	 foetal	 calf	 serum	 (FCS)	 (Appleton	
Woods),	and	5ml	(1%)	penicillin/streptomycin	(P/S)	(Sigma	Aldrich,	UK),	in	sterile	conditions.	
All	DMEM	was	stored	at	2-	4°C.	FCS	was	aliquoted	into	25ml	universals	(Appleton	Woods)	and	
P/S	 aliquoted	 into	 5ml	 bijous	 (Appleton	Woods).	 Both	were	 stored	 at	 -20°C	 until	 further	
required.		
	






















C20	 immortalised	 chondrocytes	 were	 a	 kind	 gift	 from	 Dr.	Mary	 B.	 Goldring	 (Hospital	 for	

























































The	 trypsin	 EDTA	 supernatant	 was	 poured	 off	 and	 the	 remaining	 cell	 pellets	 were	 re-
suspended	with	PBS,	at	a	ratio	of	1ml/well.	0.1ml	of	this	cell	suspension	was	mixed	with	0.1ml	
of	trypan	blue,	in	a	sterile	Eppendorf,	resulting	in	a	dilution	factor	of	2	(Fig.	2.2).	10µl	of	this	






























































































































































freshly	 prepared	 Schmorl’s	 reagent	 for	 10	 minutes.	 The	 cover	 slip	 was	 washed	 again	 in	
distilled	water	to	remove	any	residual	ferricyanide	and	then	counterstained	using	nuclear	fast	


















































duplicates,	 into	 a	 96	 well	 plate.	 The	 supernatants	 collected	 from	 experiment	 II	 were	
defrosted,	and	20µL	pipetted	into	96	well	plates.	180µL	of	DMMB	solution	was	aliquoted	into	







The	supernatants	obtained	 from	experiment	 II	were	used	 for	 this	assay.	The	supernatants	
were	therefore	derived	from	one	biological	replicate	for	each	cell	line.	At	days	4	and	8	the	
supernatant	was	derived	from	a	technical	replicate	of	6,	for	each	treatment	group	(n=1).	At	
days	12	and	14	 the	 supernatant	was	derived	 from	a	 technical	 replicate	of	 three,	 for	each	
treatment	group	(n=1).	The	measured	absorbance	values	were	interpolated	using	a	standard	
curve	 to	 obtain	 corresponding	 concentration	 values	 of	 CS.	 The	 mean	 and	 SEM	 of	 the	
Volume of 50μg/mL stock solution 
(μL) 




0 20 0 
2.5 17.5 6.25 
5 15 12.5 
7.5 12.5 18.75 
10 10 25 
12.5 7.5 31.25 
17.5 2.5 43.75 








culture	 flasks.	 Each	 cell	 line	was	 then	 passaged	 as	 described	 above	 into	 two	 flasks,	 each	
containing	 a	 CaF2	 disk.	 One	 flask	 was	 left	 untreated	 as	 a	 control.	 The	 other	 flask	 upon	
passaging	 was	 treated	 with	 HGA.	 The	 cell	 medium	 was	 pre-mixed	 with	 HGA	 in	 sterile	
universals,	 to	ensure	a	concentration	of	33µM	of	HGA.	Cells	were	then	 left	 for	three	days	
which	ensured	cells	adhered	to	and	achieved	confluency	on	the	CaF2	disks.	Cells	were	then	
gently	 rinsed	with	PBS	 solution	and	 immersed	 in	 fresh	PBS	on	an	open	petri	dish.	Raman	
spectroscopy	produces	weak	 signals	 for	 PBS	 (88).	 This	 process	 therefore	 ensures	minimal	






instrument	 was	 calibrated	 using	 silicon,	 which	 has	 a	 spectral	 band	 at	 520.5cm-1,	 and	
confirmed	using	polystyrene	at	 the	 spectral	bands	of	1001.4cm-1	and	1031.0cm-1.	 Spectral	






wavelengths	593.00cm-1	 to	1704.00cm-1,	where	biological	molecules	 are	most	 likely	 to	be	
detected	 (89).	 These	 settings	 were	 applied	 to	 both	 C20	 and	 MG63	 cell	 lines	 for	 all	
measurements.	 The	 experiment	 used	 one	 biological	 replicate	 for	 each	 cell	 line,	 with	 a	
technical	 replicate	 of	 15	 spectral	 acquisitions	 for	 each	 treatment	 group.	 15	 areas	 were	
randomly	 selected	 for	 spectral	 acquisition	 on	 each	 CaF2	 disk,	 to	 ensure	 a	 representative	
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Phenylalanine	group),	as	these	bands	did	not	fluctuate	in	signal	strength	across	all	spectra.	
Normalization	 of	 sample	 spectra	 ensures	 the	 concentration	 and	 thickness	 of	 samples	 are	
accounted	for	to	enable	comparability	(79,	90,	91).		
	
Multivariate	 analysis	 using	 principle	 component	 analysis	 (PCA)	 and	 linear	 discriminant	
analysis	(LDA)	was	then	performed	using	MATLAB	software	(The	MathWorks,	USA).	PCA	is	an	
unsupervised	 technique	 used	 to	 find	 the	most	 variance	 in	 the	 dataset.	 It	 is	 a	method	 of	





likely	 to	 contain	 99%	 of	 all	 variances	 (79,	 90).	 LDA	 is	 then	 used	 on	 top	 of	 PCA.	 LDA	 is	 a	
supervised	 technique	 which	 is	 used	 to	 discriminate	 different	 categories.	 LDA	 aims	 to	













The	 aim	 of	 this	 experiment	 was	 to	 observe	 the	 effects	 of	 SOD	 on	 immortalised	 human	
chondrocytes	and	osteosarcoma	cell	 lines.	 Studies	have	 shown	SOD	 to	be	present	at	high	
levels	in	human	cartilage	samples	(63).	However,	no	studies	have	been	conducted	to	assess	





experiment	utilises	an	 in	 vitro	model	 to	 test	 various	 concentrations	of	 SOD,	 to	assess	 cell	
viability.	As	AKU	primarily	effects	articular	cartilage,	C20	human	immortalised	chondrocytes	






























































The	 results	 suggest	 that	 in	 C20	 cell	 lines	 (Fig.	 3.1),	 SOD	 has	 no	 effect	 on	 percentage	 cell	
viability	following	seven	days	of	treatment.	This	is	seen	across	the	concentration	range	50	–	
0.05	 units/ml,	 which	 shows	 a	 greater	 percentage	 viability	 than	 the	 control.	 The	 only	




data	 shows	 there	 are	 minimal	 differences	 seen	 across	 the	 concentration	 ranges	 500-0.5	
units/ml,	when	compared	 to	 control	 cultures.	 The	 concentrations	500,	5	and	0.5	units/ml	











The	results	 indicate	that	 in	C20	and	MG63	cell	 lines,	SOD	has	no	effect	on	percentage	cell	
viability	following	seven	days	of	treatment.	5	or	0.5	units/ml	of	SOD	are	considered	the	most	
appropriate	 concentrations,	 as	 they	 show	 the	 closest	 level	 of	 viability	 to	 control	 cultures.	



































assess	 cell	 viability.	 In	 the	additional	plates,	 13mm	glass	 cover	 slips	were	added	and	 cells	
seeded	onto	them	as	previously	described.	At	days	7	and	14,	the	cover	slips	were	removed	





























































































































present	 in	 HGA	 only	 cultures	 at	 day	 7	 (Fig.	 4.4).	 The	 presence	 of	 SOD	 in	 cultures	 with	
HGA+SOD	shows	a	decrease	in	pigmentation	compared	to	HGA	alone,	reducing	it	to	a	level	
equal	to	that	of	cultures	without	HGA.	Similarly,	by	day	14	(Fig.	4.5),	C20	cells	treated	with	
HGA	 only,	 show	 an	 increase	 in	 the	 number	 of	 pigment	 deposits	 compared	 to	 other	
treatments.	 Cultures	 containing	 HGA+SOD	 demonstrate	 a	 reduction	 in	 the	 amount	 of	
pigmentation.	
	
At	 x40	 magnification,	 the	 results	 suggest	 there	 are	 no	 differences	 between	 treatment	
conditions	at	day	7	(Fig.	4.7).	By	day	14	however	(Fig.	4.8),	it	is	indicated	that	cells	treated	


































































































































magnification	 (Fig.	 4.12	 and	 Fig.	 4.13).	At	 7	days,	 the	 cells	 treated	with	only	HGA	 show	a	
significant	number	of	pigment	deposits,		whereas	there	is	a	large	decrease	in	pigmentation	
observed	in	cultures	containing	HGA+SOD.	This	trend	continues	on	day	14,	with	an	even	larger	
difference	 in	 pigmentation	 seen	 between	 cultures	 treated	 with	 HGA	 and	 HGA+SOD,	
suggesting	SOD	is	effective	in	reducing	pigmentation.		
	
















MG63	 cultures	 are	 able	 to	 tolerate	 culture	 medium	 supplemented	 with	 SOD	 and	 HGA.	
Histological	 examination	of	C20	 cultures	 shows	 that	 there	 is	 a	decrease	 in	 the	number	of	





chondrocytes.	 MG63	 cultures	 show	 contrasting	 results	 to	 C20	 cultures,	 at	 x40.	 This	 may	











































































































Fig.	 5.8.	 A	 comparison	 of	 sulphated	 GAG	 concentrations	 in	 C20	 HGA+SOD	 cultures	 across	 the	 14-day	




















results	 indicate	 that	 there	are	no	effects	on	 sulphated	GAG	release.	However,	when	each	
treatment	is	examined	across	the	14-day	treatment	period	(Fig.	5.5	–	Fig.	5.8),	the	cultures	
appear	to	release	more	sulphated	GAGs	during	the	later	stages.	This	suggests	that	if	left	for	



































Fig.	 5.13	 A	 comparison	 of	 sulphated	 GAG	 concentrations	 in	 MG63	 control	 cultures	 across	 the	 14-day	






Fig.	 5.14.	 A	 comparison	 of	 sulphated	 GAG	 concentrations	 in	 MG63	 HGA	 cultures	 across	 the	 14-day	






Fig.	 5.15.	 A	 comparison	 of	 sulphated	 GAG	 concentrations	 in	 MG63	 SOD	 cultures	 across	 the	 14-day	


















5.11	and	Fig.	5.12)	cultures	containing	SOD	show	an	 increase	 in	sulphated	GAG	release	 in	




Comparison	 of	 control	 culture	 across	 the	 14-day	 treatment	 period	 (Fig.	 5.13),	 shows	 an	
increase	in	sulphated	GAG	release	at	day	12.	This	decreases	at	day	14,	and	the	data	indicates	

























































which	 shows	 similarities	 between	 AKU	 and	 OA	 in	 the	 form	 of	 high	 density	 mineralised	
protrusions.	Originally	 thought	 to	be	disease	specific	 to	AKU,	 these	protrusions	were	 later	
found	in	OA	cartilage,	suggesting	a	new	mechanism	of	cartilage	degradation	in	OA	(1,	60,	80,	
94,	95).	Ochronotic	osteoarthropathy	 represents	an	extreme	 form	of	OA.	This	means	 that	
discoveries	 made	 from	 research	 in	 AKU	 can	 also	 have	 potential	 implications	 for	 the	
understanding	 of	 the	 pathophysiology	 of	 OA	 (1).	 Further	 structural	 analysis	 has	 shown	 a	
distinct	pattern	of	binding	of	ochronotic	pigment	on	collagen	fibrils	(32).	This	has	enabled	the	
proposal	 of	 the	exposed	 collagen	hypothesis,	 as	 this	binding	pattern	 shows	 similarities	 to	
proteoglycan	binding	(1).	
	
Structural	 analysis	 has	 enabled	 significant	 advancement	 in	AKU	 research.	 There	 is	 further	




culture	 flasks	 containing	 sterilised	 CaF2	 disks.	One	 flask	was	 left	 untreated	 and	 the	 other	
treated	with	33µM	of	HGA.	Following	three	days	of	treatment,	spectroscopic	measurements	
were	 carried	 out	 to	 determine	 the	 presence,	 if	 any,	 of	 structural	 differences	 between	
treatment	and	non-treatment	groups.	Quantitative	analysis	was	also	carried	out	with	the	aim	
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of	 HGA.	 	 Table	 correlates	 wavenumbers	 from	 the	 loadings	 plot	 to	 their	 associated	 structures.	 The	
differences	observed	on	the	loadings	plot	are	then	related	to	potential	biological	function.	
	 93	
The	 graph	 displaying	 average	 spectra	 of	 C20	 cultures	 (Fig.	 6.1),	 highlights	 key	 peaks	 for	
cartilage	components.	The	results	show	that	both	cultures	produce	Raman	signatures	at	all	
key	peaks,	suggesting	no	alterations	or	change	 in	presence	to	key	structures.	However,	at	











































for	 LD3,	 show	 no	 correlation	 to	 key	 band	 signatures	 for	 chondrocytes	 or	 osteoblasts,	
suggesting	they	are	likely	to	be	associated	with	HGA	and	its	pigment	polymer	(Fig.	6.6).	The	
peaks	 at	 1277cm-1,	 1603cm-1	 and	 between	 1660-1680cm-1	 for	 LD3	 correlate	 to	 Amide	 III,	
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Phenylalanine	and	Amide	I	respectively.	This	indicates	that	HGA	is	influencing	the	structural	





cultures	 were	 compared	 against	 C20	 HGA	 cultures.	 The	 results	 show	 that	 there	 are	
differences	between	the	two	treatment	groups,	with	only	a	minor	overlap	seen	along	LD1	
(Fig.	 6.7).	 The	 loadings	 plot	 highlights	 peaks	 between	 600-800cm-1,	 1000-1130cm-1,	 1400-
1440	and	1580-1690cm-1,	as	contributing	 to	 the	differences	between	the	 two	groups	 (Fig.	
6.8).	 Among	 these	 were	 peaks	 for	 key	 band	 signatures	 for	 chondrocytes.	 The	 peaks	 at	
1000cm-1,	 1063cm-1,	 1274cm-1	 and	 1660-1690cm-1	 correspond	 to	 Phenylalanine,	 GAG	



















the	 data	 output	 from	 PCA,	 resulting	 in	 a	 PCA-LDA	 analysis.	 PCA-LDA	 analysis	 revealed	
differences	 in	 structural	 composition	 between	 the	 two	 cell	 types	 (C20	 and	 MG63),	 and	
suggested	a	separation	between	the	two	treatment	groups	could	be	seen	if	observed	over	a	



























The	 pigmentation	 process	 in	 AKU	 is	 known	 to	 require	 molecular	 oxygen	 to	 allow	 the	












Similarities	 between	 AKU	 and	 OA	 in	 their	 pathogenic	 mechanisms	 present	 novel	 study	
opportunities	for	greater	understanding	of	AKU	(1).	Oxygen	free	radicals	are	involved	in	the	
OA	 disease	 process.	 An	 increase	 in	 the	 presence	 of	 ROS	 is	 associated	 with	 a	
downregulation/decrease	in	the	presence	of	SOD	in	articular	cartilage		(63).	AKU	is	considered	
a	rapidly	progressing	form	of	OA,	which	shows	similar	clinical	and	microscopic	presentations.	







Studies	 have	 shown	 that	 ROS	 are	 essential	 molecules	 in	 articular	 cartilage	 due	 to	 their	
intracellular	signalling	properties	(69).		It	 is	therefore	possible	to	suggest	that	at	extremely	
high	doses,	SOD	may	have	an	adverse	effect	on	articular	cartilage	through	the	prevention	of	

















The	purpose	of	 conducting	 another	 cell	 viability	 assay	was	 to	 compare	how	 cells	 tolerate	
different	treatment	conditions.	Specifically,	this	experiment	was	used	to	observe	if	HGA+SOD	












HGA	appears	relatively	stable	 in	 in	vivo	samples	as	seen	 in	fresh	serum	and	urine	samples	
from	AKU	patients,	suggesting	ochronosis	only	occurs	in	collagenous	areas	such	as	articular	





damage	 may	 be	 a	 key	 factor	 (1).	 Degenerative	 change	 in	 response	 to	 trauma	 and	 focal	
damage	changes	the	whole	extracellular	milleau	and	releases	a	variety	of	cytokines,	as	part	
of	an	inflammatory	response.	In	response	to	these	stimuli,	chondrocytes	have	been	shown	to	
produce	 IL-6,	 a	 catabolic	 cytokine.	 Research	 has	 shown	 that	 IL-6	 plays	 a	 role	 in	 the	
pigmentation	 process.	 IL-6	 has	 been	 shown	 to	 dysregulate	 antioxidant	 defences	 in	
chondrocytes	(25,	33,	34).	Furthermore	it	is	known	that	superoxide	anions	are	produced	in	
excess	during	an	inflammatory	response	(65).	It	is	possible	that	IL-6	inhibits	the	action	of	SOD	





















therefore	 is	 resistant	 to	 pigmentation.	 Pigment	 deposition	 only	 occurs	within	 osteocytes,	





It	 is	 interesting	 to	 note	 that	 in	 both	 cell	 lines,	 all	 results	 showed	 the	presence	of	 stained	
pigment	deposits	in	cultures	treated	with	SOD	only.	Schmorl’s	stain,	originally	used	to	identify	
melanin,	is	also	used	to	identify	ochronotic	pigment.	This	suggests	ochronotic	pigment	shares	












This	 experiment	 looked	 to	 see	 if	 there	was	 a	 decrease	 in	 pigmentation	 between	 cultures	




been	 able	 provide	 further	 evidence	 to	 suggest	 SOD	 was	 the	 enzyme	 responsible	 for	 the	
prevention	of	ochronosis.	However,	the	results	still	suggest	that	SOD	plays	a	preventive	role	
in	 the	 ochronotic	 process,	 indicating	 that	 HGA	 requires	 ROS	 for	 the	 initiation	 of	 the	
polymerisation	 process.	 The	 cell	 viability	 assays	 demonstrate	 that	 SOD	 does	 not	 have	 a	
detrimental	 effect	 on	 the	 cells.	 This	 suggests	 that	 SOD	 has	 the	 potential	 to	 be	 used	 as	 a	
therapeutic	approach	in	the	prevention	of	ochronosis	in	articular	cartilage.		
	











IL-6	 inhibits	 the	 action	 of	 SOD	 present	 in	 articular	 cartilage,	 enabling	 the	 polymerisation	
process.	 Using	 this	 exposed	 collagen	 hypothesis,	 a	 decrease	 in	 quantity	 of	 SOD	 in	 AKU	
cartilage,	as	seen	in	OA	cartilage,	can	be	predicted	(1,	63).	SOD	has	been	shown	to	bind	to	
proteoglycans;	if	there	is	loss	of	proteoglycans	there	is	a	subsequent	loss	of	SOD	(63,	103).	





when	 compared	 to	 control	 cultures.	 This	 suggests	 that	ROS	are	not	 involved	 in	 the	 initial	
breakdown	of	proteoglycans.	 It	 is	 therefore	 likely	 to	be	another	 factor,	 such	as	 repetitive	
mechanical	 loading	 and/or	 ageing	 and	 degradation,	 which	 changes	 the	 composition	 of	
articular	cartilage,	enabling	ochronosis	(1).		
	
There	 are	 also	 no	 differences	 indicated	 between	HGA	 treatments	 and	 control	 cultures	 in	
MG63	cultures	across	all	days.	This	suggests	that	proteoglycan	loss	in	MG63	cultures	is	also	













The	 results	 indicate	 that	 ROS	 are	 not	 involved	 in	 the	 breakdown	of	 proteoglycans.	 It	 can	






To	 enable	 the	 assessment	 of	 structural	 differences	 between	 control	 and	 HGA	 treated	
cultures,	it	is	possible	to	group	the	highlighted	peaks	in	the	average	spectra	to	their	relevant	








Similar	 Raman	 peaks	 are	 produced	 for	MG63	 and	 C20	 cultures,	 with	 peaks	 representing	
collagen	 and	 proteoglycan	 components	 present	 in	 both	 cultures.	 However,	 a	 structural	








surrounding	 environment.	 This	 is	 echoed	 by	 a	 study	 that	 has	 shown	 the	 production	 of	
















































in	 each	 collagen	 type	 is	 likely	 to	 vary	 (42,	 46,	 112).	 Another	 factor	 that	 has	 influenced	
separation	between	cell	types	is	the	presence	of	mineral	components	in	MG63	cell	cultures,	
which	are	not	present	 in	C20	 cultures.	 This	 is	 also	 to	be	expected	as	MG63	cells	produce	
minerals	which,	as	described	above,	are	not	present	on	collagen	(48,	107).		
	
Analysis	 along	 LD3	 shows	 that	 there	 may	 be	 potential	 to	 observe	 a	 distinct	 separation	
between	 control	 and	 HGA	 treated	 cultures,	 if	 analysed	 for	 a	 longer	 treatment	 period.	
Loadings	plot	analysis	for	LD3	shows	that	any	differences	seen	can	be	attributed	to	peaks	in	
between	610-750cm-1,	and	peaks	corresponding	to	collagenous	structures.	It	has	been	shown	















provided	 evidence	 to	 suggest	 that	 it	 is	 possible	 to	 distinguish	 control	 cultures	 and	 HGA	
treated	cultures	using	Raman	spectroscopy.	The	results	from	the	loadings	plot	show	that	for	
C20	 cultures,	 there	 are	 several	 peaks	 contributing	 to	 the	 differences	 seen	 between	 the	





















This	 initial	 experiment	 suggests	 that	 there	 is	 potential	 for	 Raman	 spectroscopy	 in	 the	
investigation	of	the	pathogenesis	of	AKU.	Raman	spectroscopy	has	been	shown	to	be	a	highly	









































research	has	been	conducted	on	 the	administration	of	SOD	as	a	 targeted	 therapy	 in	 vivo.	
Therefore,	 further	 work	 needs	 to	 be	 conducted	 into	 the	methods	 of	 targeting	 SOD	 as	 a	
therapy.	 Studies	 have	 shown	 SOD	 mimetics	 injected	 into	 the	 articular	 cartilage,	 have	
beneficial	 effects	 on	 rats	 induced	 with	 arthritis.	 SOD	 mimetics	 are	 currently	 undergoing	
research	 with	 the	 aims	 of	 clinical	 implementation,	 in	 the	 treatment	 of	 inflammatory	
conditions	such	as	arthritis	(65,	116).	This	suggests	that	SOD	mimetics	may	have	a	potential	





The	Raman	spectroscopy	 results	 showed	that	whilst	 structural	differences	were	observed,	
there	was	still	a	degree	of	overlap	in	both	cultures.	If	cultures	were	therefore	treated	for	a	
longer	 period	 prior	 to	 analysis,	 and	 repeat	 experiments	 had	 been	 conducted,	 a	 clearer	
distinction	may	have	been	observed.	 Furthermore,	 if	 both	 cell	 lines	were	 seeded	at	 a	 set	
number	of	cells/ml,	a	quantitative	comparison	would	have	been	possible	between	cell	lines.	
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